Dr Sheetal Goyal, Consultant Neurologist, Wockhardt Hospitals, Mumbai Central says that the greatest challenge to treating Parkinson’s is to catch it early enough to provide the best possible outcomes for patients. An insight
Parkinson’s disease is typically perceived as a tremor-and-slowness syndrome, but the reality is more far-reaching and far earlier than that. While many of these early symptoms are subtle and not motor-based, identifying them can make a genuine difference in how well the illness is controlled. Being a doctor, the greatest challenge to treating Parkinson’s is to catch it early enough to provide the best possible outcomes for patients. This is where awareness, particularly among general practitioners and frontline medical staff, becomes so critical.
While many of these early symptoms are subtle and not motor-based, identifying them can make a genuine difference in how well the illness is controlled.
Non-Motor Symptoms: The Frequently Overlooked Early Indicators
Long before any apparent tremor or movement difficulty presents itself, most patients experience alterations that appear not to be connected to a neurological disorder. One patient may say that they have been having intense dreams or behaving during sleep; this may be REM sleep behaviour disorder, an early sign of Parkinson’s. Some simply feel more depressed or anxious without any apparent cause. A variation in writing, particularly if it is becoming smaller and tighter (a symptom called micrographia), can also be an early warning sign.
Other early warning signs can be constipation, loss of smell, or inexplicable fatigue. These are shrugged off and blamed on ageing, stress, or other unrelated things, but for one who has been trained to see the patterns, they can signal something more. It is such early warning signs that present a window of opportunity for quicker intervention.
The Impact of a Delayed Diagnosis
When Parkinson’s is not diagnosed in its early phases, patients usually lose the opportunity to initiate neuroprotective measures or control symptoms before they become more restrictive. A delay can translate into faster progression of motor challenges, higher reliance on medications later on, and a greater emotional burden on both the patient and his/her family.
Early on, patients can still have the physical and mental stamina to adjust to changes in lifestyle and gain more from interventions such as physical therapy, speech therapy, or exercise programmes. If diagnosis occurs years later, the patient’s burden is typically heavier, and they might find it more difficult to deal with everyday tasks and their quality of life.
A delay can translate into faster progression of motor challenges, higher reliance on medications later on, and a greater emotional burden on both the patient and his/her family. Why General Practitioners Are Key?
Most individuals don’t visit a neurologist at the initial sign of distress, they consult their GP. This is why primary care physicians play such a crucial role in the early diagnosis of Parkinson’s. If GPs know the subtle signs and risk factors, they can facilitate getting patients to the appropriate specialists sooner. It is not always about making a firm diagnosis immediately but knowing when to refer.
GPs are best placed to observe trends between visits: a patient once springy in their step now shuffling, or someone who was always cheerful is now withdrawn and lethargic. Trends are easier to spot with a good doctor-patient relationship.
GPs are best placed to observe trends between visits: a patient once springy in their step now shuffling, or someone who was always cheerful is now withdrawn and lethargic.
Tools That Help Us Detect Parkinson’s Earlier
Early diagnosis is becoming more precise through medical equipment and research advances. Imaging such as DAT scans allows doctors to see dopamine activity in the brain, providing evidence of a diagnosis when symptoms are still minimal. Others can also be helped by evaluation through wearables or smartphone apps that monitor movement, gait, or voice changes over a while, subtle movements that humans might overlook but data can detect.
Scientists are investigating biomarkers in blood, spinal fluid, and even the skin to search for alterations associated with Parkinson's before the onset of symptoms. These are not yet standard tests, but they are promising for the future. Blending clinical observation with digital evaluation and biological markers is where we are going.
Early diagnosis is becoming more precise through medical equipment and research advances. Imaging such as DAT scans allows doctors to see dopamine activity in the brain, providing evidence of a diagnosis when symptoms are still minimal.
How Technology and AI Are Changing the Game
Artificial intelligence and machine learning are becoming valuable tools for the early detection of Parkinson’s. These tools can listen to audio recordings, and monitor keystrokes, gait movements, and even facial expressions to detect subtle signs that may not be noticeable by a clinician during a single office visit.
Certain apps now enable patients to do some simple things at home, such as tapping their fingers or speech tests, which are input into algorithms that have been trained to recognise abnormalities. These software programmes don’t supplant physicians, they aid us. They help identify patients who can profit from a more detailed neurological examination even before they realise anything is amiss themselves.
Parkinson’s disease is not simply a tremor that suddenly materialises. It is usually a series of small, subtle changes that can creep up on you. The sooner we catch it, the better we can help patients maintain their quality of life and independence. That is why it is so important for physicians, particularly those who are on the front lines of primary care, to recognise what to watch for and to follow up on those hints when they occur. As increasing tools and more intelligent technologies are at our disposal, the future of early detection is bright, and that promise can mean all the difference.
